The Safety and Efficacy of Anti-Tumor Necrosis Factor-Alpha Therapy for Inflammatory Bowel Disease in Patients Post-Liver Transplantation: A Case Series

被引：0
|
作者：
Sandhu, Amindeep S.
AlAmeel, Turki
Dale, Cheryl
Levstik, Mark
Chande, Nilesh
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S801 / S801
页数：1
相关论文
共 50 条
  • [21] Advanced Age Is Not Associated With Lower Safety and Efficacy of Anti-Tumor Necrosis Factor Therapy in the Treatment of Inflammatory Bowel Disease
    van der Vliet, Quirine M.
    van der Aalst, Karen S.
    ten Thije, Jacobus J.
    Have, Mike V.
    Sijtsma, Leonie
    van der Aalst, Anniek M.
    Ponsioen, Cyriel
    van Tuyl, Sebastiaan A.
    van der Meulen-de Jong, Andrea E.
    Oldenburg, Bas
    Fidder, Herma
    GASTROENTEROLOGY, 2015, 148 (04) : S236 - S236
  • [22] Alopecia secondary to Anti-Tumor Necrosis Factor-Alpha therapy
    Prata Ribeiro, Lara Beatriz
    Estrada, Bruna Duque
    Pineiro Maceira, Juan Manuel
    Goncalves Rego, Juliana Carlos
    Bastos, Paula Raso
    Sodre, Celso Tavares
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2015, 90 (02) : 232 - 235
  • [23] Autoimmune Pitfalls of Anti-Tumor Necrosis Factor-Alpha Therapy
    Roginic, Sinisa
    Jelic, Alan
    Stipic-Markovic, Asja
    Marinko, Artukovic
    Artukovic, Irena N.
    Dusanka, Martinovic K.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (02): : 117 - 119
  • [24] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [25] Psoriasis Associated With Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Cullen, Garret
    Kroshinsky, Daniela
    Cheifetz, Adam S.
    Korzenik, Joshua R.
    GASTROENTEROLOGY, 2011, 140 (05) : S774 - S775
  • [26] Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease in the Setting of Immunosuppression for Solid Organ Transplantation
    El-Nachef, Najwa
    Terdiman, Jonathan
    Mahadevan, Uma
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1210 - 1211
  • [27] Should patients with inflammatory bowel disease and depression be given anti-tumor necrosis factor therapy?
    Barnes, A.
    Mountifield, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 130 - 130
  • [28] Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
    Bortlik, Martin
    Duricova, Dana
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Mitrova, Katarina
    Romanko, Igor
    Bina, Vladislav
    Malickova, Karin
    Kolar, Martin
    Lukas, Milan
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (02) : 196 - 202
  • [29] Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease Reply
    Bouguen, Guillaume
    Brunet, Tanguy
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (04) : 855 - 856
  • [30] Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
    Peter, Inga
    Dubinsky, Marla
    Bressman, Susan
    Park, Andrew
    Lu, Changyue
    Chen, Naijun
    Wang, Anthony
    JAMA NEUROLOGY, 2018, 75 (08) : 939 - 946
12345